The Novartis Global Scholars Program (NGSP) is a competitive program designed for innovators from invited institutions to gain funding for breakthrough science not covered by traditional grant support. Through this program, Novartis Biomedical Research supports projects focused on novel science with the objective of being translated to drug discovery and/or clinical research.
Resources for breakthrough science
Each Scholar will receive up to 1 mil USD funding over three years along with drug-hunting expertise from dedicated Biomedical Research scientific collaborators. In addition, a dedicated alliance manager will ensure a productive collaboration environment between Novartis and the academic institution by handling all operational facets of the NGSP.
Access to inter-disciplinary expertise
Academic scholars have access to disease biology, drug-hunting and translational research expertise. Each selected scholar will join forces with other entrepreneurially motivated Novartis Biomedical Research scientists to challenge the status quo and take bold risks for potential big rewards and will have an opportunity to advance research into early development stages.
Meet the 2023 recipients of the Novartis Global Scholars Program
With these distinguished scholars, we will focus on innovative medicines to address the worldwide burden of disease.
- Carlo Rinaldi (University of Oxford)
- Jess Cardin (Yale University)
- Julian Downward (Francis Crick Institute)
- Lars Fugger (University of Oxford)
- Oliver Distler (University of Zurich)
NGSP 2022 Scholars
- Aravind Asokan (Duke University)
- Brent Ferrell (Vanderbilt University Medical Center)
- Hidetoshi Masumoto (Kyoto University)
- Magdalini Polymenidou (University of Zurich)
- Sereina Riniker (ETH Zurich)
NGSP 2021 Scholars
- Jeffrey Bode (ETH Zurich)
- Paul Bowness (University of Oxford)
- Stephanie Dakin (University of Oxford)
- Christoph Rademacher (University of Vienna)
- Adam Walker (UniQuest)
NGSP 2020 Scholars
- David Andrews (Sunnybrook Research Institute)
- Matthew Greenblatt (Weill Cornell Medicine)
- Junyeop Lee (Asan Medical Center)
- Alison Narayan (University of Michigan)
- Ellis Reinherz (Dana-Farber Cancer Institute)
- Jin Zhang (University of California, San Diego)
60 world-class institutions are participating in NGSP 2023
The following institutions have been invited to participate in the 2023 NGSP. We look forward to receiving their investigators’ proposals for innovative projects that will advance our mission to improve and extend peoples’ lives.
Academic Institution | Academic Institution | ||
---|---|---|---|
Medical University Vienna | AT | Seoul National University Hospital | KR |
University of Vienna | AT | Instituto de Medicina Molecular | PT |
Monash University | AU | Boston University | US |
University of Melbourne | AU | Brigham and Women’s Hospital | US |
UniQuest | AU | Columbia University | US |
WEHI (Walter & Eliza Hall Inst.) | AU | Weill Cornell Medicine | US |
Sunnybrook Research Institute | CA | Duke University | US |
The Hospital for Sick Children | CA | Emory University | US |
University of Toronto | CA | Fred Hutchinson Cancer Research Center | US |
ETH Zurich | CH | Mass Eye and Ear | US |
University of Basel | CH | Massachusetts General Hospital | US |
University of Geneva | CH | Morehouse School of Medicine | US |
Geneva University Hospitals | CH | Northwestern University | US |
University of Zurich | CH | Ohio State University | US |
LMU Munich | DE | Rutgers, The State University of New Jersey | US |
University Hospital Munich | DE | Schepens Eye Research Institute of Mass Eye and Ear | US |
Institut Pasteur | FR | Temple University | US |
Francis Crick Institute | GB | Tufts University | US |
Imperial College London | GB | University of California, Los Angeles | US |
University of Birmingham | GB | University of California, Berkeley | US |
University of Cambridge | GB | University of California, San Diego | US |
University of Oxford | GB | University of North Carolina at Chapel Hill | US |
Council of Scientific & Industrial Research - Centre for Cellular and Molecular Biology (CSIR-CCMB) | IN | University of Arizona | US |
Tel Aviv University | IS | University of Chicago | US |
Weizmann Institute of Science | IS | University of Massachusetts Chan Medical School | US |
Kyoto University | JP | University of Michigan | US |
Okinawa Institute of Science and Technology | JP | University of Pittsburgh | US |
Osaka University | JP | Vanderbilt University | US |
University of Tokyo | JP | Washington University in St. Louis | US |
Asan Medical Center | KR | Yale University | US |